Cargando…

Epstein–Barr virus latency programs dynamically sensitize B cells to ferroptosis

Epstein–Barr virus (EBV) causes 200,000 cancers annually. Upon B cell infection, EBV induces lipid metabolism to support B cell proliferation. Yet, little is known about how latent EBV infection, or human B cell stimulation more generally, alter sensitivity to ferroptosis, a nonapoptotic form of pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burton, Eric M., Voyer, Jewel, Gewurz, Benjamin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931387/ https://www.ncbi.nlm.nih.gov/pubmed/35275790 http://dx.doi.org/10.1073/pnas.2118300119

Ejemplares similares

Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
por: Burton, Eric M., et al.
Publicado: (2022)

Correction: Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
por: Burton, Eric M., et al.
Publicado: (2022)

B cell activation and the establishment of Epstein-Barr virus latency
Publicado: (1988)

Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
por: Messinger, Joshua E., et al.
Publicado: (2019)

Host genetics of Epstein–Barr virus infection, latency and disease
por: Houldcroft, Charlotte J, et al.
Publicado: (2015)

Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation
por: Mitra, Bidisha, et al.
Publicado: (2023)

NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
por: Ersing, Ina, et al.
Publicado: (2013)

Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast Carcinoma
por: Lorenzetti, Mario A., et al.
Publicado: (2010)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells
Publicado: (1993)

Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival
por: Liang, Jin Hua, et al.
Publicado: (2021)

Epstein-Barr virus latency switch in human B-cells: a physico-chemical model
por: Werner, Maria, et al.
Publicado: (2007)

Epstein-Barr virus protein BKRF4 restricts nucleosome assembly to suppress host antiviral responses
por: Chen, Jiao, et al.
Publicado: (2022)

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis
por: Casiraghi, Costanza, et al.
Publicado: (2012)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2017)

Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency
por: Bentz, Gretchen L., et al.
Publicado: (2019)

Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation
por: Zhang, Yuchen, et al.
Publicado: (2020)

Epstein–Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ
por: Singh, Deo R., et al.
Publicado: (2023)

Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program
por: Kozireva, Svetlana, et al.
Publicado: (2018)

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2019)

Epstein–Barr virus EBER1 and murine gammaherpesvirus TMER4 share conserved in vivo function to promote B cell egress and dissemination
por: Hoffman, Brett A., et al.
Publicado: (2019)

A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells
por: Ersing, Ina, et al.
Publicado: (2017)

To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
por: Price, Alexander M., et al.
Publicado: (2015)

Reactivation of Epstein–Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn(2+)-chelating function
por: Jiang, Lijun, et al.
Publicado: (2019)

EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus–infected B cells
por: Beer, Sophie, et al.
Publicado: (2022)

Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival
por: Wang, Liang Wei, et al.
Publicado: (2019)

DNA Methylation Enzymes and PRC1 Restrict B-cell Epstein-Barr Virus Oncoprotein Expression
por: Guo, Rui, et al.
Publicado: (2020)

An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2023)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency
por: Murata, Takayuki, et al.
Publicado: (2013)

Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency
por: Pisano, Gina, et al.
Publicado: (2017)

PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type
por: Lupey-Green, Lena N., et al.
Publicado: (2018)

STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency
por: Wang, Yuyan, et al.
Publicado: (2020)

Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells
por: Kawada, Jun‐ichi, et al.
Publicado: (2018)

Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation
por: Wang, Liang Wei, et al.
Publicado: (2019)

Epstein-Barr virus BNRF1 destabilizes SMC5/6 cohesin complexes to evade its restriction of replication compartments
por: Tung Yiu, Stephanie Pei, et al.
Publicado: (2022)

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection
por: Inagaki, Tomoki, et al.
Publicado: (2021)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gqjmpjjfm273kjiu7rlcr2flm3